These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 1695068)

  • 1. Interferon and 2',5'-oligo(A) synthetase activities in serum and blood mononuclear leukocytes of cattle after injection of bovine interferon-alpha 1.
    Perino LJ; Short EC; Burge LJ; Winter DA; Fulton RW
    Am J Vet Res; 1990 Jun; 51(6):886-92. PubMed ID: 1695068
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo 2',5'-oligoadenylate synthetase activity induced by recombinant DNA-derived bovine interferon alpha I1 in bovine alveolar macrophages and blood mononuclear cells.
    Holland SP; Fulton RW; Short EC; Wyckoff JH; Fox JC
    Am J Vet Res; 1991 Nov; 52(11):1779-83. PubMed ID: 1664669
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Induction and measurement of 2',5'-oligoadenylate synthetase in Madin-Darby bovine kidney cells and in cattle.
    Short EC; Fulton RW
    J Clin Microbiol; 1987 Sep; 25(9):1735-40. PubMed ID: 2443533
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 2'-5' oligo-A-synthetase activity in bovine peripheral blood leukocytes and alveolar macrophages exposed to recombinant interferons and tumor necrosis factor-alpha.
    Ohmann HB; Campos M; Griebel PJ; Babiuk LA
    Can J Vet Res; 1989 Apr; 53(2):161-6. PubMed ID: 2713781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum interferon level and (2'-5')oligoadenylate synthetase activity in lymphocytes during clinical interferon application.
    Lodemann E; Nitsche EM; Lang MH; Gerein V; Altmeyer P; Holzmann H; Kornhuber B
    J Interferon Res; 1985; 5(4):621-8. PubMed ID: 2418131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methods for the determination of the interferon-induced enzyme 2'-5' oligoadenylate synthetase in mononuclear blood cells.
    Bruchelt G; Beck J; Schilbach-Stückle K; Koscielniak E; Treuner J; Niethammer D
    J Clin Chem Clin Biochem; 1987 Dec; 25(12):879-88. PubMed ID: 2450958
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo and in vitro induction of (2'-5') oligoadenylate synthetase by human interferons in leukocytes from healthy donors and patients with renal cancer and hairy cell leukemia.
    Ferbus D; Billard C; Sigaux F; Thang MN; Falcoff E
    J Biol Regul Homeost Agents; 1987; 1(3):147-53. PubMed ID: 2459906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biological and clinical effects of the combination of beta- and gamma-interferons administered as a 5-day continuous infusion.
    Schiller JH; Storer B; Witt PL; Nelson B; Brown RR; Horisberger M; Grossberg S; Borden EC
    Cancer Res; 1990 Aug; 50(15):4588-94. PubMed ID: 2114942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Study of 2'5' oligo (A) synthetase in patients with metastatic renal cell carcinoma.
    Vakalikos J; Dimasis N; Peftulidis S; Galaktidou G; Kortsaris AH
    Int J Biol Markers; 1995; 10(2):113-4. PubMed ID: 7561235
    [No Abstract]   [Full Text] [Related]  

  • 10. Modulation of 2',5'-oligoadenylate synthetase in patients treated with alpha-interferon: effects of dose, schedule, and route of administration.
    Merritt JA; Ball LA; Sielaff KM; Meltzer DM; Borden EC
    J Interferon Res; 1986 Jun; 6(3):189-98. PubMed ID: 3745984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 2',5' oligoadenylate synthetase activity in bovine peripheral blood mononuclear cells following bovine herpesvirus type-1-induced respiratory disease: a prognostic indicator?
    Bielefeldt Ohmann H; Campos M; Harland R; Griebel PJ; Babiuk LA
    J Interferon Res; 1989 Apr; 9(2):159-66. PubMed ID: 2715670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biologic response (antiviral) to recombinant human interferon alpha 2a as a function of dose and route of administration in healthy volunteers.
    Witter F; Barouki F; Griffin D; Nadler P; Woods A; Wood D; Lietman P
    Clin Pharmacol Ther; 1987 Nov; 42(5):567-75. PubMed ID: 2445516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetic study of a human recombinant interferon (Re-IFN-alpha A) in cynomolgus monkeys by 2'-5' oligoadenylate synthetase assay.
    Bannai H; Tatsumi M; Kohase M; Onishi E; Yamazaki S
    Jpn J Med Sci Biol; 1985 Jun; 38(3):113-24. PubMed ID: 2999483
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CpG oligodeoxynucleotide induction of antiviral effector molecules in sheep.
    Nichani AK; Kaushik RS; Mena A; Popowych Y; Dent D; Townsend HG; Mutwiri G; Hecker R; Babiuk LA; Griebel PJ
    Cell Immunol; 2004 Jan; 227(1):24-37. PubMed ID: 15051512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2',5'-Oligoadenylate synthetase levels in patients with multiple myeloma receiving maintenance therapy with interferon alpha 2b do not correlate with clinical response.
    Millar BC; Bell JB
    Br J Cancer; 1995 Dec; 72(6):1525-30. PubMed ID: 8519671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential induction of 2',5'-oligoadenylate synthetase by IFN-beta ser and IFN-alpha 2 in serum-supplemented and serum-free HL-60 leukemic cell cultures.
    Fraioli M; Wu JM
    J Biol Regul Homeost Agents; 1989; 3(3):112-7. PubMed ID: 2624146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo and in vitro induction of 2'-5' oligoadenylate synthetase by interferon-alpha in nodular non-Hodgkin's lymphoma and correlations with the clinical response.
    Ferbus D; Khosravi S; Dumont J; Billard C
    J Biol Regul Homeost Agents; 1990; 4(4):127-34. PubMed ID: 2096597
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of (2'-5') oligo-adenylate synthetase and interferon blood-levels in mice early after viral infection.
    Schattner A; Merlin G; Shapira A; Revel M; Wallach D
    J Interferon Res; 1982; 2(2):285-9. PubMed ID: 6181178
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basal and interferon-induced 2',5'-oligoadenylate synthetase in human monocytes, lymphocytes, and peritoneal macrophages.
    Witt PL; Spear GT; Helgeson DO; Lindstrom MJ; Smalley RV; Borden EC
    J Interferon Res; 1990 Aug; 10(4):393-402. PubMed ID: 2121851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A phase I study of recombinant interferon-beta in patients with advanced malignant disease.
    Ravandi F; Estrov Z; Kurzrock R; Breitmeyer JB; Maschek BJ; Talpaz M
    Clin Cancer Res; 1999 Dec; 5(12):3990-8. PubMed ID: 10632330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.